News releases - Merck.com
WEBSep 17, 2024 — FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Adult Patients With Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM) September 17, 2024.
FDA approves Merck's drug for rare, deadly lung condition
WEBMar 26, 2024 — The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the drugmaker and for patients...
FDA Approves Merck’s WINREVAIR™ (sotatercept-csrk), a First ...
WEBMar 26, 2024 — WINREVAIR is the first FDA-approved activin signaling inhibitor therapy for PAH, representing a new class of therapy that works by improving the balance between pro- and anti-proliferative signaling to regulate vascular cell proliferation underlying PAH. WINREVAIR logo (Graphic: Merck & Co., Inc.)
Merck Enters Two Strategic Collaborations to Strengthen AI ...
WEBSep 20, 2023 — Merck, a leading science and technology company, today announced two new strategic drug discovery collaborations aimed at harnessing powerful artificial intelligence (AI)-driven design and discovery capabilities, further advancing the company’s research efforts.
Merck Provides Update on Phase 3 MOVe-AHEAD Trial Evaluating ...
WEBFeb 21, 2023 — MOVe-AHEAD (MK-4482-013) (NCT04939428) was a Phase 3 multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of orally administered LAGEVRIO (molnupiravir) compared to placebo in preventing the spread of SARS-CoV-2, the virus that causes COVID-19, within households.
Merck’s $11.5 Billion Bet on Its Next Big Drug Finally ...
WEBMar 26, 2024 — Merck MRK 0.53% is making a big bet that its new drug, approved Tuesday in the U.S. for a potentially fatal lung disease, will take the company a long way toward heading off a massive revenue ...
News & Stories - Merck
WEBSep 12, 2024 — Check out the latest Merck news and stories! Learn more about the leading science and technology company here.
Merck & Co., Inc. (MRK) Latest Stock News & Headlines - Yahoo ...
WEBGet the latest Merck & Co., Inc. (MRK) stock news and headlines to help you in your trading and investing decisions.
Merck Receives Priority Review from FDA for New Biologics ...
WEBSep 28, 2023 — RAHWAY, N.J.-- ( BUSINESS WIRE )--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has accepted for...
Merck Launches First Ever AI Solution to Integrate Drug ...
WEBDec 5, 2023 — Merck, a leading science and technology company, today launched its AIDDISON™ drug discovery software, the first software-as-a-service platform that bridges the gap between virtual molecule ...